DEVS vs RARE · rev $25.8K vs rev $560.2M
DevvStream Corp. Common Stock (DEVS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
DEVS currently screens at market cap $13.4M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the DEVS and RARE stock pages for the full models.
Not investment advice.